Has Htin Aung, MD received payments from drug or device companies?

Yes. Drug and device makers reported $12,310 in general payments to Htin Aung, MD across 142 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Htin Aung, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Htin Aung, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Htin Aung, MD

Interventional Cardiology · Fairhope, ALNPI 1982040580

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $8,009 of the $12,310 with a category attached, or 65.1%. 16 manufacturers reported payments, led by Abbott at 42.4% of the total. Reporting peaked in 2023 at $4,373 and has fallen 65.8% since, to $1,498 in 2025.

$12,310in general payments, 2019–2025

Across 142 payments — averaging $86.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$5K
Philips North America LLC$2K
Edwards Lifesciences$2K
Medtronic$1K
Abiomed$527
Boston Scientific$385
plus $882 from 10 others

What the payments were for

Travel & lodging$3,88132%
Food & beverage$8,00965%
Education$4203%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	43	$5,223
Philips North America LLC	35	$2,215
Edwards Lifesciences	22	$1,910
Medtronic(2 entities)	14	$1,169
Abiomed	5	$527
Boston Scientific	5	$385
Heartflow, Inc.	1	$142
Angiodynamics, Inc.	3	$139
Siemens Medical Solutions USA, Inc.	2	$129
Penumbra, Inc.	2	$104
Biotronik Inc.	1	$87
Cardiovascular Systems Inc.	4	$74
Shockwave Medical, Inc	2	$71
Asahi Intecc USA, Inc.	1	$60
Getinge USA Sales, LLC	1	$51
Cordis US CORP.	1	$25

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

MitraClip$3,236
TENDYNE$1,042
Impella$466
Edwards SAPIEN 3 Transcatheter Heart Valve$424
Resolute$420
COREVALVE EVOLUT R$347
(6575) Coronary Undivided$330
ELCA$321
Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$155
Watchman$146
SAPIEN 3 Ultra RESILIA$143
FFRct$142

How this compares

$12,310 in reported general payments places this provider in the 70th percentile of 109 interventional cardiology providers in Alabama.

See all interventional cardiology providers in Alabama →

Medicare billing

Part B allowed, 2024

$118,768

Medicare patients

514

Services billed

979

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	241	$251,336
EntrestoSacubitril/Valsartan	81	$88,254
Repatha SureclickEvolocumab	79	$82,643
XareltoRivaroxaban	39	$47,748
BrilintaTicagrelor	19	$18,577
FarxigaDapagliflozin Propanediol	29	$16,190
JardianceEmpagliflozin	14	$13,170
Praluent PenAlirocumab	13	$7,273
VascepaIcosapent Ethyl	14	$7,209
Ranolazine ErRanolazine	52	$3,815
Metoprolol Succinate	350	$3,210
Ezetimibe	179	$3,048
Isosorbide Mononitrate ErIsosorbide Mononitrate	243	$2,254
Atorvastatin Calcium	278	$1,660
Bumetanide	30	$1,511

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Fairhope

Gary RoubinBirmingham$157K
Michael ButlerHuntsville$109K
Pochana ReddyHuntsville$100K
Robert FosterBirmingham$90K
Hasan GuvenBirmingham$86K
John GallaMobile$82K
Areen Al-TaieFlorence$69K
Abdullah MahmoodBirmingham$61K
Ali EbrahimiBirmingham$55K
Jacob TownsendBirmingham$52K

See the full list for Alabama →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →